Annual report just released.
Only updated info is that they confirmed that the phase 2 trial of bit 225 for HCV patients should be completed by the end of year.
Other than that, nothing else of significance other than the chairman's confidence in the company by buying 1.4 million shares in the 2009/2010 financial year.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.645M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $1.242K | 402.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 33 | 20381479 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 19899480 | 17 |
View Market Depth
| Last trade - 10.01am 19/09/2025 (20 minute delay) ? |
| BIT (ASX) Chart |